We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Partners EnvisionRx on 90-day Health Program
Read MoreHide Full Article
Leading drugstore chain Walgreens, a part of the first global pharmacy-led, health and well-being enterprise Walgreens Boots Alliance, Inc. (WBA - Free Report) , announced a 90-day pharmacy program in collaboration with EnvisionRx, the pharmacy benefit management (PBM) division of EnvisionRxOptions. This health program called Rx90 emphasizes on changing behaviors and improving health conditions in a rising number of patients with chronic conditions.
The health program offers patients the option to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide for the same price as home delivery through EnvisionPharmacies’ mail service. The program intends to offer patients with total clinical care and health advice from EnvisionRx and Walgreens pharmacists and to curb down medical expenses related to clinical visits and hospitalizations.
Walgreens has always focused on offering better pharmacy solutions to its customers and patients. Management of Walgreens is positive on working with EnvisionRx to create a new solution, which can benefit patients, health plans and employers.
This latest alliance is expected to prove beneficial for Walgreens’ business as cooperation with PBMs and health plans are important in today’s healthcare setting to ensure the availability of medications at affordable prices along with efficient pharmacy support.
According to a Ken Research report, future growth of pharmacy retail market is expected to be led by acceleration in over-the-counter drugs segment and online pharmacies. With a number of drugs (worth $150 billion as per a global generic drugs market 2016 report) waiting to lose their patent by 2020, this is a lucrative opportunity for both drug retailers and PBM companies to reap profits.
Walgreen’s retail pharmacy segment recorded positive numbers in the recently concluded third quarter. The company is confident about the success of its ongoing pharmacy programs aimed at offering affordable medications.
Other recent developments include the company’s partnership with the U.S. Department of Health and Human Services (HHS) for a free flu vaccination program. The company has also made an effort to fight prescription drug abuse through collaboration with American Pharmacists Association (APhA).
Zacks Rank & Key Picks
Walgreens currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical product sector are GW Pharmaceuticals plc , NuVasive, Inc. and Quidel Corp. (QDEL - Free Report) . All these stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Walgreens Partners EnvisionRx on 90-day Health Program
Leading drugstore chain Walgreens, a part of the first global pharmacy-led, health and well-being enterprise Walgreens Boots Alliance, Inc. (WBA - Free Report) , announced a 90-day pharmacy program in collaboration with EnvisionRx, the pharmacy benefit management (PBM) division of EnvisionRxOptions. This health program called Rx90 emphasizes on changing behaviors and improving health conditions in a rising number of patients with chronic conditions.
The health program offers patients the option to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide for the same price as home delivery through EnvisionPharmacies’ mail service. The program intends to offer patients with total clinical care and health advice from EnvisionRx and Walgreens pharmacists and to curb down medical expenses related to clinical visits and hospitalizations.
Walgreens has always focused on offering better pharmacy solutions to its customers and patients. Management of Walgreens is positive on working with EnvisionRx to create a new solution, which can benefit patients, health plans and employers.
WALGREENS BAI Price
WALGREENS BAI Price | WALGREENS BAI Quote
This latest alliance is expected to prove beneficial for Walgreens’ business as cooperation with PBMs and health plans are important in today’s healthcare setting to ensure the availability of medications at affordable prices along with efficient pharmacy support.
According to a Ken Research report, future growth of pharmacy retail market is expected to be led by acceleration in over-the-counter drugs segment and online pharmacies. With a number of drugs (worth $150 billion as per a global generic drugs market 2016 report) waiting to lose their patent by 2020, this is a lucrative opportunity for both drug retailers and PBM companies to reap profits.
Walgreen’s retail pharmacy segment recorded positive numbers in the recently concluded third quarter. The company is confident about the success of its ongoing pharmacy programs aimed at offering affordable medications.
Other recent developments include the company’s partnership with the U.S. Department of Health and Human Services (HHS) for a free flu vaccination program. The company has also made an effort to fight prescription drug abuse through collaboration with American Pharmacists Association (APhA).
Zacks Rank & Key Picks
Walgreens currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical product sector are GW Pharmaceuticals plc , NuVasive, Inc. and Quidel Corp. (QDEL - Free Report) . All these stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>